BIOXYNE LIMITED has not announced any current capital raises, but we are collecting interest for future raises.
1. Create Account
Complete your onboarding digitally in less than 3 minutes.
2. View Terms
View the full term sheet for the capital raise.
3. Bid for Allocation
Submit and track your bid online.
Bioxyne Limited (BXN) is an Australian life science, health and medical technology company with a focus on immune health and immunotherapeutic products. Bioxyne has a strategic investment in the consumer dietary supplements and functional foods markets through its proprietary probiotic, Lactobacillus fermentum PCC. Former Names VRI Biomedical Ltd; Probiomics Limited (PCC), 5/04/2012
Suite 506, Level 5/50 Clarence St, Sydney NSW 2000, Australia
Fresh Equities does not have BIOXYNE LIMITED quarterly cash flows data.
Fresh Equities does not have BIOXYNE LIMITED directors data.